Trending:
News
-
21 March 2019
RTI Surgical starts enrolment in Fortilink devices’ FORTE study
Surgical implant developer RTI Surgical has started patient enrolment in the FORTE clinical study to evaluate its Fortilink-C, -TS and -L Interbody Fusion (IBF) systems.
-
21 March 2019
Oxford BioDynamics to assess EpiSwitch in prostate cancer trial
UK-based biotechnology company Oxford BioDynamics has partnered with Imperial College London to test its EpiSwitch biomarker assay in the PROSTAGRAM trial for prostate cancer diagnosis.
-
20 March 2019
FDA warns J&J unit and Sientra over breast implant compliance
The US Food and Drug Administration (FDA) has sent warning letters to a Johnson & Johnson unit, Mentor Worldwide, and Sientra for failure to comply with its post-approval study requirements...
-
20 March 2019
ABL to distribute TGen’s new TB test
The Translational Genomics Research Institute (TGen) in the US has signed a licensing agreement with integrated diagnostics firm Advanced Biological Laboratories (ABL) to market its tuberculosis (TB) test technology.
-
20 March 2019
New dopamine sensor could help detect brain disorders rapidly
University of Central Florida (UCF) researchers have developed a rapid detector for dopamine that could help diagnose brain conditions such as Parkinson’s disease and depression.
-
19 March 2019
Researchers develop new test for prostate cancer
An international research team led by University College Dublin (UCD) in Ireland has developed epiCaPture, a new test that detects prostate cancer using urine samples.
-
19 March 2019
Medtronic’s TYRX envelope cuts infections in cardiac implant patients
Medtronic has reported positive results from the WRAP-IT clinical trial.
-
19 March 2019
Alcon acquires intraocular lens implant manufacturer PowerVision
Alcon has acquired US-based medical device development company PowerVision in a $285m deal.
-
18 March 2019
Biotronik receives FDA approval for new cardiac devices
Biotronik has secured approval from the US Food and Drug Administration (FDA) for the use of its Acticor and Rivacor cardiac rhythm management (CRM) devices to treat heart arrhythmias.
-
18 March 2019
Ohio State researchers identify biomarkers of fibromyalgia
Researchers from Ohio State University have identified the specific biomarkers of fibromyalgia, differentiating it from other related diseases.
Go Top
